Axon Enterprise, Inc $AXON Stock Sold by N10 Wealth LLC

N10 Wealth LLC lowered its position in Axon Enterprise, Inc (NASDAQ:AXON) by 12.7% in the third quarter, Holdings Channel.com reports. The firm owned 12,196 shares of the biotechnology company’s stock after selling 1,778 shares during the quarter. Axon Enterprise makes up about 1.4% of N10 Wealth LLC’s holdings, making the stock its 26th largest position. N10 Wealth LLC’s holdings in Axon Enterprise were worth $5,153,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Keating Financial Advisory Services Inc. purchased a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $31,000. Wealth Enhancement Trust Services Inc. acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $33,000. Washington Trust Advisors Inc. boosted its stake in shares of Axon Enterprise by 1,300.0% in the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after buying an additional 65 shares in the last quarter. Delos Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the second quarter valued at approximately $45,000. Finally, Owl Creek Wealth Partners LLC boosted its stake in shares of Axon Enterprise by 84.8% in the second quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 39 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the company’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. This represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 47,397 shares of company stock valued at $26,722,984. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON traded down $11.35 during trading on Wednesday, hitting $402.00. 386,623 shares of the stock were exchanged, compared to its average volume of 1,047,241. The company has a fifty day moving average price of $511.34 and a two-hundred day moving average price of $475.41. The company has a market cap of $32.66 billion, a PE ratio of 166.80, a P/E/G ratio of 7.80 and a beta of 1.44. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter in the prior year, the firm posted $2.12 EPS. The company’s revenue was up 35.3% compared to the same quarter last year. On average, analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Monday, October 5th. TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a report on Tuesday. Barclays boosted their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Morgan Stanley upped their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, UBS Group raised their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.